GeneFerm Biotechnology Co Ltd
TPEX:1796
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GeneFerm Biotechnology Co Ltd
TPEX:1796
|
TW |
|
A
|
Aoxin Q & M Dental Group Ltd
SGX:1D4
|
SG |
|
W
|
WIIK PCL
SET:WIIK
|
TH |
|
White River Bancshares Co
OTC:WRIV
|
US |
|
G6 Materials Corp
OTC:GPHBF
|
US |
|
L
|
Lion One Metals Ltd
F:LY1
|
CA |
|
Brazilian Rare Earths Ltd
F:X84
|
AU |
|
W
|
Waypoint Biomedical Holdings Inc
OTC:WYPH
|
US |
|
A
|
Amundi SA
F:ANI
|
FR |
|
Provenance Gold Corp
OTC:PVGDF
|
CA |
|
U
|
Universe Pharmaceuticals Inc
NASDAQ:UPC
|
CN |
|
Infomedia Ltd
OTC:IFMDF
|
AU |
Dividends
Dividend Yield
GeneFerm Biotechnology Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
GeneFerm Biotechnology Co Ltd
Payout Ratio
GeneFerm Biotechnology Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for GeneFerm Biotechnology Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
GeneFerm Biotechnology Co Ltd
| Average Annual Return | 15.78% |
| Standard Deviation of Annual Returns | 38.69% |
| Max Drawdown | -81% |
| Market Capitalization | 1.3B TWD |
| Shares Outstanding | 41 460 000 |
| Percentage of Shares Shorted |
N/A
|
